Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statgraphics01:10

Statgraphics

Statgraphics is a comprehensive statistical software suite designed for both basic and advanced data analysis. Originating in 1980 at Princeton University under Dr. Neil W. Polhemus, it was one of the pioneering tools for statistical computing on personal computers, with its public release in 1982 marking an early milestone in data science software. Over the years, it has evolved into a robust platform for data science, offering tools for regression analysis, ANOVA, multivariate statistics,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+ /HER2 - metastatic breast cancer: A translational analysis of the GEICAM/2013-02 PEARL trial.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Bird mortality on high-speed railways: lessons from two large contrasting species.

Scientific reports·2025
Same author

Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials.

The oncologist·2025
Same author

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

JCO precision oncology·2025
Same author

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Statistics and decision making in high-throughput screening.

Isabel Coma1, Jesus Herranz, Julio Martin

  • 1Molecular Discovery Research, Glaxo SmithKline, Tres Cantos, Madrid, Spain.

Methods in Molecular Biology (Clifton, N.J.)
|June 25, 2009
PubMed
Summary
This summary is machine-generated.

Statistical tools are essential for making informed decisions in high-throughput screening (HTS) by managing experimental variability and guiding hit identification. This approach ensures reliable data interpretation and effective drug discovery.

More Related Videos

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
06:19

High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

Published on: March 10, 2023

Related Experiment Videos

Last Updated: Jun 22, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography
06:19

High-Throughput Screening to Obtain Crystal Hits for Protein Crystallography

Published on: March 10, 2023

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Biology

Background:

  • Screening experiments involve decision-making regarding compound activity on biological systems.
  • Experimental results exhibit inherent variability, necessitating statistical approaches for reliable interpretation.
  • Statistics provides the framework for decision-making under uncertainty in scientific research.

Purpose of the Study:

  • To highlight the critical role of statistical tools in analyzing screening experiments.
  • To demonstrate how statistical methods aid in decision-making throughout the high-throughput screening (HTS) workflow.
  • To guide the interpretation of screening data for valuable information and sound decision-making.

Main Methods:

  • Focus on statistical tools for assay development, HTS process monitoring, and primary data analysis.
  • Review of statistical process control for HTS campaign quality.
  • Methodologies for detecting and managing HTS patterns to avoid bias.
  • Approaches for statistically guided hit selection in HTS.

Main Results:

  • Statistical tools are crucial for assessing assay quality and ensuring screening production readiness.
  • Statistical process control monitors HTS campaign performance and detects potential biases.
  • Pattern detection and mitigation methods improve the reliability of HTS data.
  • Statistically guided hit selection enhances the accuracy of identifying active compounds.

Conclusions:

  • The application of statistical tools is fundamental to robust HTS workflows.
  • Statistics enables informed decision-making at key HTS stages: assay development, campaign monitoring, and hit identification.
  • Utilizing statistical methods transforms raw screening data into actionable insights for drug discovery.